2:08 PM
 | 
Dec 01, 2017
 |  BC Week In Review  |  Company News  |  Deals

Acorda cashes out on Selincro royalties

H. Lundbeck A/S (CSE:LUN) will pay Acorda Therapeutics Inc. (NASDAQ:ACOR) $13 million to eliminate milestone...

Read the full 53 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >